OpenAlex
PricingAboutJobs
Log inGet started
Work

Multicentre determination of rezafungin (CD101) susceptibility of Candida species by the EUCAST method

HTML PDF

Year: 2018
Type: article
Source: Clinical Microbiology and Infection
DOI: 10.1016/j.cmi.2018.02.021
Authors: M.C. Arendrup, J. Meletiadis, O. Zaragoza, K.M. Jørgensen, L.J. Marcos-Zambrano, L. Kanioura, M. Cuenca-Estrella, J.W. Mouton, J. Guinea
Institutions: Statens Serum Institut, University of Copenhagen, Rigshospitalet, National and Kapodistrian University of Athens, Erasmus MC, University General Hospital Attikon, Instituto de Salud Carlos III, Hospital General Universitario Gregorio Marañón, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Centro de Investigación Biomédica en Red, Instituto de Investigación Sanitaria Gregorio Marañón
Language: English

Topic: Antifungal resistance and susceptibility
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: rezafungin, CD101, echinocandins, Candida, antifungal susceptibility, EUCAST, inter-laboratory variability, Candida albicans, Candida parapsilosis, Candida glabrata, Candida krusei, Candida tropicalis, invasive candidiasis, minimum inhibitory concentration, quality control strains
SDG: Good health and well-being

Open Access status: bronze

Funder: Cidara Therapeutics
OpenAlex ID: W2791773668
FWCI: 3.067
Cites: 19
Cited by: 47
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security